NMSIC Co-Investment Fund, L.P.

Track

Insider profile

Performance

Overall performance
1.1
Performance over holding periods
1.1
30 days 90 days 120 days
Average return -33% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
NMSIC Co-Investment Fund, L.P.'s trades of Exagen Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Exagen Inc (XGN)
Transaction date
Sale
Price
83.40
Quantity 25,002 -50.0%
Value US$4,096,564
US Exagen Inc (XGN)
Transaction date
Sale
Price
196.52
Quantity 2,463 -41.5%
Value US$368,125
US Exagen Inc (XGN)
Transaction date
Sale
Price
307.54
Quantity 51,796 +34.9%
Value US$791,945
US Exagen Inc (XGN)
Transaction date
Sale
Price
12.50
Quantity 126,404 -4.9%
Value US$1,580,050
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-03-27 2025-03-25
US Exagen Inc (XGN)
S Sale
25,002 -50.0%
83.40
US$4,096,564 		25,002 -50.0% 83.40 US$4,096,564
2024-11-27 2024-11-20
US Exagen Inc (XGN)
S Sale
2,463 -41.5%
196.52
US$368,125 		2,463 -41.5% 196.52 US$368,125
2020-12-16 2020-12-15
US Exagen Inc (XGN)
S Sale
51,796 +34.9%
307.54
US$791,945 		51,796 +34.9% 307.54 US$791,945
2020-09-03 2020-09-01
US Exagen Inc (XGN)
S Sale
126,404 -4.9%
12.50
US$1,580,050 		126,404 -4.9% 12.50 US$1,580,050